jehan
Reflections on Patient-Focused Drug Development (PFDD) Public Workshop of December 18, 2017
We were very happy to have Farrah Pompilus represent Modus Outcomes at the inaugural FDA PFDD public workshop as an attendee in December 2017. It is encouraging to see that the FDA will be developing four guidance documents to further ensure greater patient-focused input throughout the regulatory process. We trust that these new documents will […]
Patient-Centered Drug Development: Reflections, Challenges, & Solutions: The Success Story Continues
Following the success of our inaugural event in May 2017, and an overwhelming demand to host a second roundtable workshop, we were pleased to host our second invitation-only event “Patient-Centered Drug Development: Reflections, Challenges, & Solutions” on November 8th, 2017 at the Glasgow Science Center, Glasgow, Scotland. During this exclusive event we brought together strategic […]
Patient-centered outcomes in rare diseases: breakthrough paper co-authored by Thomas Morel (KU Leuven) and Stefan Cano (Modus Outcomes):
Learn in this article how a concept-driven measurement approach addresses the many challenges of evaluating direct treatment benefit in rare diseases. Modus Outcomes’ team has developed successful concept-driven measurement solutions for sponsors in rare diseases. More specifically, we can help you: Run a tailored workshop on the lessons from the paper Apply these solutions to […]